2022
Overview
Progressive diseases are neurological conditions characterized by gradual worsening of symptoms and function over time, resulting from ongoing degeneration of nervous system structures. Research published in Neurological Research and Therapy examines both the molecular foundations and clinical manifestations of these conditions. The journal has featured investigations into Tay-Sachs disease, exploring its molecular characterization alongside the ethical considerations surrounding genetic medicine approaches for this inherited neurodegenerative disorder. Additionally, the journal has published cohort research examining multiple sclerosis severity, specifically analyzing disability progression and identifying prognostic factors that influence disease trajectory in patient populations. These studies reflect the dual importance of understanding progressive diseases at both the cellular level, where pathological processes unfold, and the clinical level, where practitioners must assess disease course and inform patient care decisions. The topic holds significant relevance because progressive neurological diseases present unique challenges in diagnosis, prognosis, and management, requiring ongoing research to identify factors that influence disease progression and to evaluate potential interventions that might slow or modify the degenerative process.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2023
How this research is being cited
The 2 articles above have been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.
-
2024 · medRxiv (Cold Spring Harbor Laboratory)
A sample of recent works citing this journal's research on Progressive Diseases, linking to each citing work.